Winship Cancer Institute of Emory University
Mehmet Asim Bilen, MD, is associate professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. A board certified medical oncologist, Dr. Bilen is actively involved in clinical research and patient care in the area of genitourinary cancers. He serves as director of the Genitourinary Medical Oncology Program at Winship Cancer Institute of Emory University. He works closely with the Fellowship Program of the Department of Hematology and Medical Oncology by educating fellows on genitourinary oncology. He also serves on the Winship Clinical and Translational Review Committee. Dr. Bilen is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute.
Disclosure(s): Advisory board: Exelixis, Bayer, BMS, Eisai, Pfizer, AstraZeneca, Janssen, Calithera Biosciences, Genomic Health, Nektar, EMD Serono, SeaGen, and Sanofi (Ongoing)
Contract Research: Amgen, Merck, Xencor, Bayer, Bristol-Myers Squibb, Genentech/Roche, SeaGen, Incyte, Nektar, AstraZeneca, Tricon Pharmaceuticals, Genome & Company, AAA, Peloton Therapeutics, and Pfizer (Ongoing)